Research and experimental development on natural sciences and engineering
ZELLUNA IMMUNOTHERAPY AS
Revenue 2024
NOK 53,000
Operating profit
NOK −109.6m
Equity
NOK 36.0m
Incorporated
2016
Employees
9
Share capital
NOK 2.0m
Roles
Daglig lederNamir Jafar Hassan
Regnskapsfører
Regnskapsfører
Revisor
Styrets lederAnders Tuv
StyremedlemGeir Christian Melen
StyremedlemNamir Jafar Hassan
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ZELLUNA ASA | 100.0% | 13524826.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.